Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 5/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.37 |
| ▸ | HCAR3 | P49019 | 4/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13420124 | 0.83 | HCAR3 (0.38) | APPHCAR3TDO2ALDH1A1 | |
| SCHEMBL18307133 | 0.81 | HCAR3 (0.56) | HCAR3HPGDSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL7353325 | 0.77 | APP (0.42) | APPHCAR3HPGDSMN1; SMN2 | |
| SCHEMBL3754896 | 0.77 | CYP2C19 (0.56) | HCAR3TDO2HPGDSMN1; SMN2 | |
| SCHEMBL17082679 | 0.76 | HCAR3 (0.53) | HCAR3HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL12212247 | 0.74 | HCAR3 (0.36) | HCAR3HPGDSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL6986721 | 0.74 | HCAR3 (0.45) | HCAR3TDO2HPGDSMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2562040 | 0.73 | HCAR3 (0.35) | HCAR3HPGDSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL2998111 | 0.73 | NMT1 (0.48) | CYP1A2 | |
| SCHEMBL21666862 | 0.72 | EDNRA (0.36) | HCAR3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192901-A9 | QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023192901-A1 | QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |